ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
12.80
+0.24 (1.91%)
Mar 14, 2025, 4:00 PM EDT - Market closed
ClearPoint Neuro Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 31.39 | 23.96 | 20.55 | 16.3 | 12.83 | Upgrade
|
| Revenue Growth (YoY) | 31.04% | 16.56% | 26.09% | 27.05% | 14.37% | Upgrade
|
| Cost of Revenue | 12.27 | 10.34 | 7.02 | 5.18 | 3.71 | Upgrade
|
| Gross Profit | 19.12 | 13.61 | 13.53 | 11.12 | 9.12 | Upgrade
|
| Selling, General & Admin | 26.48 | 24.35 | 18.97 | 15.22 | 10.65 | Upgrade
|
| Research & Development | 12.39 | 11.71 | 10.89 | 9.28 | 4.69 | Upgrade
|
| Operating Expenses | 38.87 | 36.06 | 29.86 | 24.5 | 15.34 | Upgrade
|
| Operating Income | -19.75 | -22.45 | -16.33 | -13.37 | -6.22 | Upgrade
|
| Interest Expense | - | - | -0.08 | -0.97 | -1.44 | Upgrade
|
| Interest & Investment Income | 0.87 | 0.39 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.02 | -0.06 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -18.91 | -22.09 | -16.44 | -14.41 | -7.68 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.9 | Upgrade
|
| Pretax Income | -18.91 | -22.09 | -16.44 | -14.41 | -6.78 | Upgrade
|
| Net Income | -18.91 | -22.09 | -16.44 | -14.41 | -6.78 | Upgrade
|
| Net Income to Common | -18.91 | -22.09 | -16.44 | -14.41 | -6.78 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 25 | 24 | 21 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 25 | 24 | 21 | 16 | Upgrade
|
| Shares Change (YoY) | 9.85% | 1.75% | 16.63% | 30.82% | 20.48% | Upgrade
|
| EPS (Basic) | -0.70 | -0.90 | -0.68 | -0.69 | -0.43 | Upgrade
|
| EPS (Diluted) | -0.70 | -0.90 | -0.68 | -0.69 | -0.43 | Upgrade
|
| Free Cash Flow | -9.23 | -14.44 | -16.42 | -12.87 | -7.85 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.59 | -0.68 | -0.62 | -0.50 | Upgrade
|
| Gross Margin | 60.92% | 56.83% | 65.84% | 68.24% | 71.09% | Upgrade
|
| Operating Margin | -62.91% | -93.70% | -79.47% | -82.05% | -48.48% | Upgrade
|
| Profit Margin | -60.25% | -92.21% | -79.97% | -88.41% | -52.86% | Upgrade
|
| Free Cash Flow Margin | -29.39% | -60.27% | -79.90% | -78.93% | -61.17% | Upgrade
|
| EBITDA | -18.77 | -21.82 | -16.09 | -13.22 | -5.89 | Upgrade
|
| EBITDA Margin | -59.78% | -91.09% | -78.28% | -81.08% | -45.88% | Upgrade
|
| D&A For EBITDA | 0.98 | 0.63 | 0.24 | 0.16 | 0.33 | Upgrade
|
| EBIT | -19.75 | -22.45 | -16.33 | -13.37 | -6.22 | Upgrade
|
| EBIT Margin | -62.91% | -93.70% | -79.47% | -82.05% | -48.48% | Upgrade
|
| Revenue as Reported | 31.39 | 23.96 | 20.55 | 16.3 | 12.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.